Pular para o conteúdo principal

Watch this robot construct the world’s biggest botmade building by itself

In just half a day, a new type of robot built an igloo-shaped building half the diameter of the U.S. Capitol dome—all by itself. In the future, such autonomous machines could assemble entire towns, create wacky Dr. Seuss–like structures, and even prepare the moon for its first human colony.
“It’s an impressive project,” says Matthias Kohler, an architect who studies autonomous construction at ETH Zurich in Switzerland, but was not involved in the work.
People have experimented with many approaches to autonomous construction, and the scientists—a team from the Massachusetts Institute of Technology’s (MIT’s) materials science and design focused Mediated Matter lab in Cambridge—weighed them all before designing their robot. Should their robot manufacture prefabricated parts in a distant factory? If it works on site, should it be crane-shaped? Should they create a swarm of builder drones? And what about the construction materials—should the robot assemble buildings from blocks? The scientists chose to go with a mobile, mechanical arm for easy customization and wider reach, and they decided to print buildings layer by layer, for more complex shapes.
Their solution consists of a large hydraulic arm on motorized tanklike treads (which you can watch at work, above). At the end of the arm is a smaller electric arm for finer movements, armed with a suite of sensors for positioning and stability control, along with swappable tools for welding, digging, and printing. The combined reach of the arms is more than 10 meters. The Digital Construction Platform, as it’s called, also carries solar panels and batteries.
To put the bot through its paces, the scientists programmed it to drive out of a warehouse and build an open-top dome using a method they developed called print-in-place: The electronic tip sprays a line of expanding foam that creates the outline of the structure. Layer by layer, the robot uses the foam to build up a hollow wall that serves as insulation and can later be filled with concrete and covered in plaster. To show its ability to print horizontally, the bot even added a bench to a wall. At 14.6 meters across, the structure is the largest building ever 3D-printed by a mobile robot, the researchers report today in Science Robotics. It’s also the fastest to be printed: 13.5 hours.
Several elements of the new bot made the feat possible. For example, the group made an “interesting leap forward” by putting lasers at the end of the arm to sense the tip’s position and help it counteract any unwanted movement in the rest of the arm, instead of keeping the whole thing perfectly stable, Kohler says. The technique, which has never before been used in a construction bot, allows the entire machine to be lightweight and have a huge reach. David Wilson, a mechanical engineer and the chief innovation officer at Bechtel in Houston, Texas (the contractor responsible for the Hoover Dam), says that the micro-macro manipulators and print-in-place method offer new potential.
Aside from the safety advantages, autonomous 3D printing is faster and more precise than manual construction. It can also maximize building strength and efficiency by placing material only where it’s needed, and it simplifies planning and logistics. Steven Keating, the MIT mechanical engineer who led the project, imagines seeing the exact time, cost, and structural integrity of a building before even hitting “print.” Robots also allow for almost any design you can dream up. “Instead of making a square building,” he says, “you can make a Dr. Seuss–looking building for the same cost.”
The new robot can also build smaller structures from sand, compressed earth, metal chains (which it welds together), and even ice (which it deposits first as water). Such resourcefulness would be useful if it’s ever in a remote environment and has to build with whatever’s at hand. It can dig, sense various environmental cues including radiation (which could help it repair nuclear reactors), and print walls with variations in color or stiffness for further customization and efficiency. Keating would love to see the robot go to Mars, design a structure based on local ground and weather conditions, collect its own energy and materials, and then put up a house—or even a town.
For the moment, the building machine still needs a little help from its human friends. At one point, dew settled on the dome, causing a layer of foam to slide off the structure before it could fully adhere. Keating had to swap out the printing tip for a chainsaw and backtrack. But because print-in-place uses standard materials, the MIT researchers say it can be used alongside traditional construction techniques, paving a path toward code certification.
“We wanted to have the dream, the future vision,” Keating says, “and also something that we could implement right away.” Some people can hardly wait. The team has already been getting calls from NASA, the U.S. military, Google, and one guy who saw the dome and made a special request for a famous client: an underground basketball court.
Posted by David Araripe

Comentários

Postagens mais visitadas deste blog

CONSERVAÇÃO DE ALIMENTOS E A EQUAÇÃO DE ARRHENIUS por Carlos Bravo Diaz, Universidade de Vigo, Espanha

Traduzido por Natanael F. França Rocha, Florianópolis, Brasil  A conservação de alimentos sempre foi uma das principais preocupações do ser humano. Conhecemos, já há bastante tempo, formas de armazenar cereais e também a utilização de azeite para evitar o contato do alimento com o oxigênio do ar e minimizar sua oxidação. Neste blog, podemos encontrar diversos ensaios sobre os métodos tradicionais de conservação de alimentos. Com o passar do tempo, os alimentos sofrem alterações que resultam em variações em diferentes parâmetros que vão definir sua "qualidade". Por exemplo, podem sofrer reações químicas (oxidação lipídica, Maillard, etc.) e bioquímicas (escurecimento enzimático, lipólise, etc.), microbianas (que podem ser úteis, por exemplo a fermentação, ou indesejáveis caso haja crescimento de agentes patogênicos) e por alterações físicas (coalescência, agregação, etc.). Vamos observar agora a tabela abaixo sobre a conservação de alimentos. Por que usamo...

Two new proteins connected to plant development discovered by scientists

The discovery in the model plant Arabidopsis of two new proteins, RICE1 and RICE2, could lead to better ways to regulate plant structure and the ability to resist crop stresses such as drought, and ultimately to improve agricultural productivity, according to researchers at Texas A&M AgriLife Research. Credit: Graphic courtesy of Dr. Xiuren Zhang, Texas A&M AgriLife Research The discovery of two new proteins could lead to better ways to regulate plant structure and the ability to resist crop stresses such as drought, thus improving agriculture productivity, according to researchers at Texas A&M AgriLife Research. The two proteins, named RICE1 and RICE2, are described in the May issue of the journal eLife, based on the work of Dr. Xiuren Zhang, AgriLife Research biochemist in College Station. Zhang explained that DNA contains all the information needed to build a body, and molecules of RNA take that how-to information to the sites in the cell where they can be used...

Fármaco brasileiro aprovado nos Estados Unidos

  Em fotomicrografia, um macho de Schistosoma mansoni, causador da esquistossomose CDC/G. Healy A agência que regula a produção de alimentos e medicamentos dos Estados Unidos, a FDA, concedeu o status de orphan drug para o fármaco imunomodulador P-Mapa, desenvolvido pela rede de pesquisa Farmabrasilis, para uso no tratamento de esquistossomose.  A concessão desse status é uma forma de o governo norte-americano incentivar o desenvolvimento de medicamentos para doenças com mercado restrito, com uma prevalência de até 200 mil pessoas nos Estados Unidos, embora em outros países possa ser maior. Globalmente, a esquistossomose é uma das principais doenças negligenciadas, que atinge cerca de 200 milhões de pessoas no mundo e cerca de 7 milhões no Brasil.  Entre outros benefícios, o status de orphan drug confere facilidades para a realização de ensaios clínicos, após os quais, se bem-sucedidos, o fármaco poderá ser registrado e distribuído nos Estados Unidos, no Brasil e em outro...